1.23
price down icon1.60%   -0.02
after-market After Hours: 1.17 -0.06 -4.88%
loading

Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News

pulisher
Feb 24, 2025

Anebulo Pharmaceuticals enters lock-up agreement, faces Nasdaq compliance issue By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Anebulo Pharmaceuticals enters lock-up agreement, faces Nasdaq compliance issue - Investing.com

Feb 24, 2025
pulisher
Feb 22, 2025

Anebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders - MSN

Feb 22, 2025
pulisher
Feb 20, 2025

Anebulo Pharmaceuticals Reports Fiscal Q2 2025 Results - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Anebulo Pharmaceuticals Inc Files Prospectus Related To Resale Of 15.2 Million Shares Of Common Stock By Selling Stockholders- SEC Filing - Marketscreener.com

Feb 20, 2025
pulisher
Feb 14, 2025

Anebulo Pharmaceuticals Inc. (ANEB) reports earnings - Quartz

Feb 14, 2025
pulisher
Feb 14, 2025

Anebulo Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Anebulo Pharmaceuticals, Inc. SEC 10-Q Report - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Anebulo's Cannabis Overdose Treatment Gets FDA Priority Signal as Company Raises $15M - StockTitan

Feb 14, 2025
pulisher
Feb 13, 2025

Head to Head Contrast: ProQR Therapeutics (NASDAQ:PRQR) versus Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Anebulo Pharmaceuticals sets annual meeting for April 4, 2025 By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

Anebulo Pharmaceuticals sets annual meeting for April 4, 2025 - MSN

Feb 12, 2025
pulisher
Feb 04, 2025

Anebulo Pharmaceuticals Leads This Trio Of US Penny Stocks - Yahoo Finance

Feb 04, 2025
pulisher
Jan 29, 2025

Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Increases By 2,174.1% - Defense World

Jan 29, 2025
pulisher
Jan 14, 2025

Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Expands By 2,174.1% - Defense World

Jan 14, 2025
pulisher
Dec 30, 2024

3 US Penny Stocks With Market Caps Under $800M - Yahoo Finance

Dec 30, 2024
pulisher
Dec 26, 2024

Anebulo Pharmaceuticals sees $9.99m stock acquisition by 22NW fund - Investing.com Australia

Dec 26, 2024
pulisher
Dec 24, 2024

Anebulo Pharmaceuticals collaborates with FDA to advance selonabant - Yahoo Finance

Dec 24, 2024
pulisher
Dec 23, 2024

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise - BioSpace

Dec 23, 2024
pulisher
Dec 23, 2024

Anebulo Pharmaceuticals secures $15 million capital raise - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

Anebulo Reports Breakthrough Clinical Data for Cannabis Toxicity Treatment, Secures $15M Funding - StockTitan

Dec 23, 2024
pulisher
Dec 20, 2024

Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Down 9.8% – Should You Sell? - Defense World

Dec 20, 2024
pulisher
Dec 18, 2024

Anebulo Pharmaceuticals stock hits 52-week low at $1.23 - Investing.com India

Dec 18, 2024
pulisher
Dec 18, 2024

Anebulo Pharmaceuticals stock hits 52-week low at $1.23 By Investing.com - Investing.com South Africa

Dec 18, 2024
pulisher
Nov 23, 2024

Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024
pulisher
Nov 22, 2024

Anebulo Pharmaceuticals stock hits 52-week low at $1.25 By Investing.com - Investing.com Australia

Nov 22, 2024
pulisher
Nov 21, 2024

Anebulo Pharmaceuticals stock hits 52-week low at $1.25 - Investing.com India

Nov 21, 2024
pulisher
Nov 20, 2024

Anebulo Pharmaceuticals Advances Cannabis Toxicity Solutions - MSN

Nov 20, 2024
pulisher
Nov 14, 2024

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates - Defense World

Nov 14, 2024
pulisher
Nov 13, 2024

Anebulo Pharma Secures $1.9M NIDA Grant for Cannabis Toxicity Treatment Development | ANEB Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 07, 2024

Anebulo Pharmaceuticals stock hits 52-week low at $1.72 - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Anebulo Pharmaceuticals stock hits 52-week low at $1.72 By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Oct 29, 2024

Exxaro Resources (OTCMKTS:EXXAY) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Oct 29, 2024
pulisher
Oct 29, 2024

Lexeo Therapeutics’ (LXEO) “Buy” Rating Reiterated at Chardan Capital - Defense World

Oct 29, 2024
pulisher
Oct 29, 2024

Short Interest in Janone Inc. (NASDAQ:ALTS) Expands By 10.2% - Defense World

Oct 29, 2024
pulisher
Oct 23, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.21% - MSN

Oct 23, 2024
pulisher
Oct 17, 2024

Anebulo Pharmaceuticals Updates Corporate Presentation - TipRanks

Oct 17, 2024
pulisher
Oct 04, 2024

Anebulo To Report Acute Cannabinoid Intoxication Trial Data In June - RTTNews

Oct 04, 2024
pulisher
Oct 01, 2024

Benchmark maintains Speculative Buy on Anebulo stock By Investing.com - Investing.com Canada

Oct 01, 2024
pulisher
Oct 01, 2024

Anebulo Pharmaceuticals (NASDAQ:ANEB) Earns "Speculative Buy" Rating from Benchmark - MarketBeat

Oct 01, 2024
pulisher
Sep 27, 2024

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 27.7% in September - Defense World

Sep 27, 2024
pulisher
Sep 25, 2024

Anebulo Pharmaceuticals reports Q4 EPS (5c) vs. (10c) last year - TipRanks

Sep 25, 2024
pulisher
Sep 25, 2024

Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended June 30, 2024 - Marketscreener.com

Sep 25, 2024
pulisher
Sep 25, 2024

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates - Business Wire

Sep 25, 2024
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):